Continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia

Contraception

Volumn 80, Issue 6, 2009, Pages 527-532

  Harvey, Caroline ^a   Seib, Charrlotte ^b   Lucke, Jayne ^c  

^a Family Planning Queensland   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Clinical audit; Contraception; Discontinuation; Etonogestrel implant; Implanon

Indexed keywords

ETONOGESTREL;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DEVICE REMOVAL; FAMILY PLANNING; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; MOOD CHANGE; NORMAL HUMAN; RURAL AREA; URBAN AREA; VAGINA BLEEDING; WEIGHT GAIN;

ADULT; CHI-SQUARE DISTRIBUTION; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; COUNSELING; DESOGESTREL; DEVICE REMOVAL; FEMALE; HUMANS; MEDICAL RECORDS; METRORRHAGIA; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; QUEENSLAND; RETROSPECTIVE STUDIES;

EID: 70350780567     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.05.132     Document Type: Article

References (17)

1. Weisberg E., and Fraser I. Australian women's experience with Implanon. Aust Fam Physician 34 (2005) 694-696
2. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception 58 6 Suppl (1998) 99S-107S
3. Croxatto H.B., Urbancsek J., Massai R., Coelingh Bennink H., and van Beek A. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod 14 (1999) 976-981
4. Mansour D., Korver T., Marintcheva-Petrova M., and Fraser I.S. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 13 Suppl 1 (2008) 13-28
5. Halpern V., Grimes D.A., Lopez L., and Gallo M.F. Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst Rev (2006) CD004317
6. Hubacher D., Goco N., Gonzalez B., and Taylor D. Factors affecting continuation rates of DMPA. Contraception 60 (1999) 345-351
7. Belsey E.M., and Task Force on Long-Acting Systemic Agents for Fertility Regulation. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 38 (1988) 207-225
8. Tolley E., Loza S., Kafafi L., and Cummings S. The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt. Int Fam Plan Perspect 31 (2005) 15-23
9. Lei Z.W., Wu S.C., Garceau R.J., et al. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. Contraception 53 (1996) 357-361
10. Agrawal A., and Robinson C. An assessment of the first 3 years' use of Implanon in Luton. J Fam Plann Reprod Health Care 31 (2005) 310-312
11. Lakha F., and Glasier A.F. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception 74 (2006) 287-289
12. Rai K., Gupta S., and Cotter S. Experience with Implanon in a northeast London family planning clinic. Eur J Contracept Reprod Health Care 9 (2004) 39-46
13. Smith A., and Reuter S. An assessment of the use of Implanon in three community services. J Fam Plann Reprod Health Care 28 (2002) 193-196
14. National Health and Medical Research Council. When does quality assurance in health care require independent ethical review? (2003), Commonwealth of Australia, Canberra. http://www.nhmrc.gov.au/publications/synopses/e46syn.htm Available from:
15. National Collaborating Centre for Women's and Children's Health. Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception (2005), RCOG Press, London. http://www.nice.org.uk/CG030 Commissioned by the National Institute for Health and Clinical Excellence. Available from:
16. Montano D.E., and Phillips W.R. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health 85 (1995) 795-800
17. Fleming D., Davie J., and Glasier A. Continuation rates of long-acting methods of contraception. Contraception 57 (1998) 19-21